Muutke küpsiste eelistusi

Targeting Enzymes for Pharmaceutical Development: Methods and Protocols Second Edition 2026 [Kõva köide]

Edited by
  • Formaat: Hardback, 596 pages, kõrgus x laius: 254x178 mm, 97 Illustrations, color; 13 Illustrations, black and white
  • Sari: Methods in Molecular Biology
  • Ilmumisaeg: 14-Jun-2026
  • Kirjastus: Humana
  • ISBN-10: 1071651897
  • ISBN-13: 9781071651896
Teised raamatud teemal:
  • Kõva köide
  • Hind: 133,04 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 177,39 €
  • Säästad 25%
  • See raamat ei ole veel ilmunud. Raamatu kohalejõudmiseks kulub orienteeruvalt 3-4 nädalat peale raamatu väljaandmist.
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Hardback, 596 pages, kõrgus x laius: 254x178 mm, 97 Illustrations, color; 13 Illustrations, black and white
  • Sari: Methods in Molecular Biology
  • Ilmumisaeg: 14-Jun-2026
  • Kirjastus: Humana
  • ISBN-10: 1071651897
  • ISBN-13: 9781071651896
Teised raamatud teemal:
This second edition volume expands on the previous edition with a discussion of the latest experimental and computational strategies used in the study, characterization, and targeting of enzymes with therapeutic potential. The chapters in the book are organized into two parts: Part One presents detailed, reproducible protocols for enzyme characterization, inhibitor screening, and biochemical analysis. Part Two is dedicated to computational and in silico methodologies, reflecting the growing impact of computational biology in drug discovery. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.

Cutting-edge and authoritative, Targeting Enzymes for Pharmaceutical Development: Methods and Protocols, Second Edition is a valuable resource for academic and industrial scientists in medicinal chemistry, chemical biology, pharmaceutical biotechnology, structural biology, and computational drug discovery. This book is both a technical manual and conceptual guide for scientists engaged in enzyme-related drug discovery and development.
Measuring Protein-Ligand Binding by Thermal Shift Assay.- Applications
of Differential Scanning Fluorimetry and Related Technologies in
Characterization of Protein-Ligand Interactions.- Enzyme-Ligand Interaction
Monitored by Synchrotron Radiation Circular Dichroism.- Binding Interaction
Analysis of Lysozyme and Brilliant Blue using Surface Plasmon
Resonance.- Evaluation of Endolysin Activity Using Nephelometric Assays with
Whole Bacterial Cells and Isolated Peptidoglycan.- In Vitro Assays for
Endolysin Efficacy and Safety Profiling.- Droplet-Based Microfluidics Methods
for Detecting Enzyme Inhibitors.- HMG-CoA Reductase Inhibition Assays:
Updated Protocols for Drug Discovery and Enzyme Kinetics.- The Enzyme-Bag
Platform for Cytochrome P450 Biotransformation and High-Throughput Drug
Metabolism Screening.- Enzymatic Bioautographic Methods.- On-Line
Enantioselective Capillary Electrophoretic Method for Screening Cytochrome
P450 3A4 Inhibitors.- Isolation and Endopeptidase Inhibition of Human
2-Macroglobulin.- Harnessing Affinity Tags for Recombinant Protein
Purification: Concepts, Methods, and Troubleshooting.- Computational
Strategies for Discovering Inhibitors Targeting Therapeutic Enzymes.-
Computational Study of Enzyme Inhibition.- In Silico Laboratory: New and
Updated Tools for Protein-Centered Drug Discovery.- Combined In Silico
Approaches for Virtual Screening of Non-Covalent Immunoproteasome Inhibitors
for Multiple Myeloma Treatment.- Deep Learning Pipeline for Accelerating
Virtual Screening in Drug Discovery.- In Silico Methodology for Human
Carboxylesterases 1 and 2 Isoforms Substrate Selectivity Study.